Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study.

Science
Share

First published in British Journal of Clinical Pharmacology on 2013 Dec.
Br J Clin Pharmacol. 2013 Dec;76(6):888-96. doi: 10.1111/bcp.12129.

Authors: Brossard P, Derendorf H, Xu J, Maatouk H, Halabi A, Dingemanse J

 

 

 

 

Read more

Download full article as Pdf file:

Pdf File

 

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board
located at CRS Mannheim

LET’S TALK SCIENCE
Dr. Marc Hetzel

VP & Head of Business Development
located at CRS Management

LET’S TALK BUSINESS

You May Also Like

Science 30. Januar 2023
Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects.
Science 30. Januar 2023
Midazolam microdosing applied in early clinical development for drug-drug interaction assessment.
Science 30. Januar 2023
The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive – A randomized controlled trial.